387 related articles for article (PubMed ID: 9824105)
41. Pseudallescheria boydii (Anamorph Scedosporium apiospermum). Infection in solid organ transplant recipients in a tertiary medical center and review of the literature.
Castiglioni B; Sutton DA; Rinaldi MG; Fung J; Kusne S
Medicine (Baltimore); 2002 Sep; 81(5):333-48. PubMed ID: 12352630
[TBL] [Abstract][Full Text] [Related]
42. Scedosporium apiospermum: An unreported cause of fungal sporotrichoid-like lymphocutaneous infection in Australia and review of the literature.
Boyce Z; Collins N
Australas J Dermatol; 2015 May; 56(2):e39-42. PubMed ID: 24266687
[TBL] [Abstract][Full Text] [Related]
43. Scedosporium/Pseudallescheria infections.
Panackal AA; Marr KA
Semin Respir Crit Care Med; 2004 Apr; 25(2):171-81. PubMed ID: 16088460
[TBL] [Abstract][Full Text] [Related]
44. Cutaneous infection due to Scedosporium apiospermum in an immunosuppressed patient.
Chaveiro MA; Vieira R; Cardoso J; Afonso A
J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):47-9. PubMed ID: 12602968
[TBL] [Abstract][Full Text] [Related]
45. Towards proteomic species barcoding of fungi - An example using Scedosporium/Pseudallescheria complex isolates.
Bernhard M; Zautner AE; Steinmann J; Weig M; Groß U; Bader O
Fungal Biol; 2016 Feb; 120(2):162-5. PubMed ID: 26781372
[TBL] [Abstract][Full Text] [Related]
46. Pseudallescheria boydii (Scedosporium species) in 3 lung transplant recipients: computed tomography findings and literature review.
Sheu R; Bricker AO; Sahi H; Mohammed TL
J Comput Assist Tomogr; 2009; 33(2):247-52. PubMed ID: 19346854
[TBL] [Abstract][Full Text] [Related]
47. Susceptibility and diversity in the therapy-refractory genus scedosporium.
Lackner M; Hagen F; Meis JF; Gerrits van den Ende AH; Vu D; Robert V; Fritz J; Moussa TA; de Hoog GS
Antimicrob Agents Chemother; 2014 Oct; 58(10):5877-85. PubMed ID: 25070092
[TBL] [Abstract][Full Text] [Related]
48. [Scedosporium apiospermum disseminated infection in a single lung transplant recipient].
Solé A
Rev Iberoam Micol; 2011; 28(3):139-42. PubMed ID: 21700235
[TBL] [Abstract][Full Text] [Related]
49. Scedosporium apiospermum keratitis treated with itraconazole.
Saracli MA; Erdem U; Gonlum A; Yildiran ST
Med Mycol; 2003 Apr; 41(2):111-4. PubMed ID: 12964842
[TBL] [Abstract][Full Text] [Related]
50. Organ-specific variation in the morphology of the fungomas (fungus balls) of Pseudallescheria boydii. Development within necrotic host tissue.
Schwartz DA
Arch Pathol Lab Med; 1989 May; 113(5):476-80. PubMed ID: 2712671
[TBL] [Abstract][Full Text] [Related]
51. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii.
Gilgado F; Cano J; Gené J; Sutton DA; Guarro J
J Clin Microbiol; 2008 Feb; 46(2):766-71. PubMed ID: 18077629
[TBL] [Abstract][Full Text] [Related]
52.
Furnica DT; Dittmer S; Scharmann U; Meis JF; Steinmann J; Rath PM; Kirchhoff L
Microbiol Spectr; 2023 Jun; 11(3):e0513022. PubMed ID: 37017567
[TBL] [Abstract][Full Text] [Related]
53. Infection with Scedosporium apiospermum and S. prolificans, Australia.
Cooley L; Spelman D; Thursky K; Slavin M
Emerg Infect Dis; 2007 Aug; 13(8):1170-7. PubMed ID: 17953087
[TBL] [Abstract][Full Text] [Related]
54. Tricuspid valve and pacemaker endocarditis due to Pseudallescheria boydii (Scedosporium apiospermum).
Laurini JA; Carter JE; Kahn AG
South Med J; 2009 May; 102(5):515-7. PubMed ID: 19373137
[TBL] [Abstract][Full Text] [Related]
55. Cutaneous Pseudallescheria boydii/Scedosporium apiospermum complex infection in immunocompromised patients: A report of two cases.
Tsuji G; Takei K; Takahara M; Matsuda T; Nakahara T; Furue M; Uchi H
J Dermatol; 2017 Sep; 44(9):1067-1068. PubMed ID: 27666328
[No Abstract] [Full Text] [Related]
56. Maxillary sinusitis: isolation of Scedosporium (Monosporium) apiospermum, anamorph of Petriellidium (Allescheria) boydii.
Bloom SM; Warner RR; Weitzman I
Mt Sinai J Med; 1982; 49(6):492-4. PubMed ID: 6984735
[No Abstract] [Full Text] [Related]
57. Identifying the emerging human pathogen Scedosporium prolificans by using a species-specific monoclonal antibody that binds to the melanin biosynthetic enzyme tetrahydroxynaphthalene reductase.
Thornton CR; Ryder LS; Le Cocq K; Soanes DM
Environ Microbiol; 2015 Apr; 17(4):1023-38. PubMed ID: 24684242
[TBL] [Abstract][Full Text] [Related]
58. Molecular variability of Pseudallescheria boydii, a neurotropic opportunist.
Rainer J; de Hoog GS; Wedde M; Gräser Y; Gilges S
J Clin Microbiol; 2000 Sep; 38(9):3267-73. PubMed ID: 10970369
[TBL] [Abstract][Full Text] [Related]
59. Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification.
Bronnimann D; Garcia-Hermoso D; Dromer F; Lanternier F; ;
Med Mycol; 2021 May; 59(5):486-497. PubMed ID: 33037432
[TBL] [Abstract][Full Text] [Related]
60. Scedosporium infection in immunocompromised patients: successful use of liposomal amphotericin B and itraconazole.
Barbaric D; Shaw PJ
Med Pediatr Oncol; 2001 Aug; 37(2):122-5. PubMed ID: 11496350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
